Insight Wealth Strategies LLC Boosts Stock Holdings in Centene Co. (NYSE:CNC)

Insight Wealth Strategies LLC boosted its position in Centene Co. (NYSE:CNCFree Report) by 2.2% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 26,497 shares of the company’s stock after purchasing an additional 569 shares during the period. Insight Wealth Strategies LLC’s holdings in Centene were worth $2,079,000 as of its most recent SEC filing.

Several other institutional investors have also bought and sold shares of CNC. Operose Advisors LLC purchased a new position in Centene in the third quarter valued at approximately $25,000. Turtle Creek Wealth Advisors LLC purchased a new stake in shares of Centene during the fourth quarter worth $25,000. Riggs Asset Managment Co. Inc. purchased a new stake in shares of Centene during the fourth quarter worth $32,000. Headinvest LLC purchased a new stake in shares of Centene during the third quarter worth $35,000. Finally, Neo Ivy Capital Management purchased a new stake in shares of Centene during the fourth quarter worth $40,000. Hedge funds and other institutional investors own 93.63% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently commented on CNC shares. Stephens reissued an “equal weight” rating and issued a $83.00 target price on shares of Centene in a research note on Thursday, May 30th. Oppenheimer reissued an “outperform” rating and issued a $110.00 target price on shares of Centene in a research note on Monday, April 29th. Robert W. Baird started coverage on Centene in a research note on Thursday, May 30th. They issued a “neutral” rating and a $83.00 target price on the stock. Baird R W raised Centene to a “hold” rating in a research note on Thursday, May 30th. Finally, Cantor Fitzgerald reissued an “overweight” rating and issued a $90.00 target price on shares of Centene in a research note on Wednesday, June 12th. Eight research analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, Centene presently has a consensus rating of “Moderate Buy” and an average target price of $84.93.

Read Our Latest Analysis on CNC

Centene Trading Down 2.7 %

Shares of NYSE CNC traded down $1.81 during trading hours on Wednesday, hitting $66.39. The company’s stock had a trading volume of 3,945,887 shares, compared to its average volume of 3,534,281. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.17 and a current ratio of 1.17. The stock has a market cap of $35.43 billion, a price-to-earnings ratio of 13.20, a P/E/G ratio of 0.88 and a beta of 0.47. Centene Co. has a 12 month low of $60.83 and a 12 month high of $81.42. The business has a 50-day simple moving average of $73.42 and a 200-day simple moving average of $75.28.

Centene (NYSE:CNCGet Free Report) last posted its earnings results on Friday, April 26th. The company reported $2.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.09 by $0.17. Centene had a return on equity of 14.19% and a net margin of 1.76%. The company had revenue of $40.41 billion for the quarter, compared to analysts’ expectations of $36.43 billion. During the same period last year, the firm earned $2.11 earnings per share. Centene’s quarterly revenue was up 3.9% on a year-over-year basis. On average, analysts anticipate that Centene Co. will post 6.82 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Centene news, Director Christopher J. Coughlin sold 878 shares of the firm’s stock in a transaction dated Tuesday, May 14th. The shares were sold at an average price of $76.75, for a total value of $67,386.50. Following the completion of the sale, the director now directly owns 25,504 shares in the company, valued at $1,957,432. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other news, Director Christopher J. Coughlin sold 878 shares of Centene stock in a transaction that occurred on Tuesday, May 14th. The shares were sold at an average price of $76.75, for a total transaction of $67,386.50. Following the completion of the transaction, the director now directly owns 25,504 shares in the company, valued at $1,957,432. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, President Kenneth J. Fasola sold 8,000 shares of Centene stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $77.62, for a total transaction of $620,960.00. Following the transaction, the president now owns 300,357 shares of the company’s stock, valued at $23,313,710.34. The disclosure for this sale can be found here. 0.29% of the stock is currently owned by company insiders.

Centene Company Profile

(Free Report)

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.

Recommended Stories

Institutional Ownership by Quarter for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.